Author

María Chaparro Sanchez 1

1 Hospital Universitario de La Princesa, IIS-Princesa, UAM and CIBERehd, Madrid, Spain

EFFECTIVENESS AND SAFETY OF SWITCHING FROM ADALIMUMAB REFERENCE TO BIOSIMILAR IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: THE ADA-SWITCH STUDY

María José Casanova, María Chaparro Sanchez, Oscar Nantes, Pilar Varela, Milagros Vela Gonzalez, Montserrat Rivero, Olivia Sierra-Gabarda, Sabino Riestra, Manuel Barreiro de Acosta, María del Mar Martín-Rodríguez, Carla Jerusalén Gargallo-Puyuelo, Cristina Reygosa, Roser Muñoz Pérez, Irene García de la filia Molina, Andrea Nú

EFFECTIVENESS AND SAFETY OF VEDOLIZUMAB AND USTEKINUMAB THERAPY FOR COMPLEX PERIANAL FISTULA IN CROHN’S DISEASE: THE HEAL STUDY

María José Casanova, María Chaparro Sanchez, Berta Caballol, María José García, Francisco Mesonero, Cristina Rubín de Célix, Patricia Suárez Álvarez, Rocío Ferreiro-Iglesias, María del Mar Martín-Rodríguez, Ruth María de Francisco García, Pilar Varela Trastoy, Guillermo Bastida, Marta Carrillo Palau, Andrea Núñez-Ortiz, Patri

PROTEOMIC PROFILE OF SERUM AND URINE IN NEWLY DIAGNOSED PATIENTS WITH INFLAMMATORY BOWEL DISEASE: NEW APPROACH FOR BIOMARKER DISCOVERY

Montse Baldan Martin, Mikel Azkargorta, Ibon Iloro, Lorena Ortega Moreno, Laila Aldars-García, Irene Soleto, Cristina Ramírez, SABINO RIESTRA MENENDEZ, Montserrat Rivero Tirado, Ana Gutiérrez-Casbas, Iago Rodríguez-Lago, Luis Fernández-Salazar, Daniel Sebastian Ceballos Santos, José Manuel Benítez, Mariam Aguas, Iria Bastón-

REAL-WORLD EVIDENCE OF THE EFFECTIVENESS AND SAFETY OF USTEKINUMAB FOR THE TREATMENT OF CROHN’S DISEASE: SYSTEMATIC REVIEW AND META-ANALYSIS OF OBSERVATIONAL STUDIES

Cristina Rubín de Célix, María Chaparro Sanchez, Javier P. Gisbert*

Item 1 - 4 / 4
1